- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01135576
Iron Fortified Beverages and Application in Women Predisposed to Anemia (FeDrink)
December 21, 2012 updated by: M Pilar Vaquero, National Research Council, Spain
- The objective of the study is to know if consumption of an iron fortified fruit juice containing micronized iron pyrophosphate, is useful to increase iron status in women predisposed to iron deficiency anemia.
- A secondary objective is to know if consumption of this iron fortified fruit juice modifies bone remodelling.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
122
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women
- non-smoker
- non-pregnant
- non-breastfeeding
- serum ferritin <40 ng/ml
- hemoglobin>=11g/dl
Exclusion Criteria:
- Serum Ferritin >=40 ng/ml
- Hemoglobin <11g/dl
- Amenorrhea
- Menopause
- Iron deficiency anemia
- Thalassemia
- Hemochromatosis
- Blood donors
- Chronic gastric diseases
- Renal diseases
- Eating disorders
- Allergy to any component of the study juices
- Consumption of iron or ascorbic acid supplements within 4 month prior to participating in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo juices
Consumption of non-iron fortified fruit juices as part of the usual diet
|
|
|
Experimental: Iron fortified fruit juices
Consumption of iron fortified fruit juices as part of the usual diet
|
Consumption of micronized iron pyrophosphate supplemented fruit juices as part of the usual diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Serum Ferritin
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Serum transferrin
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Hemoglobin
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
serum iron
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
transferrin saturation
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
soluble transferrin receptor
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
zinc protoporphyrin
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Total red blood cells
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Hematocrit
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Mean corpuscular volume
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Red blood cell distribution width
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
25-hydroxycholecalciferol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
alkaline phosphatase bone-isoenzyme (ALP)
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
serum cross-linked N-telopeptide of type I collagen (NTx)
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Total cholesterol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
HDL-cholesterol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
LDL-cholesterol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Glucose
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Serum triacylglycerols
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
T-chol/HDL-chol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
LDL-chol/HDL-chol
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Systolic blood pressure
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
|
Diastolic blood pressure
Time Frame: monitored during 16 weeks
|
monitored during 16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Navas-Carretero S, Perez-Granados AM, Schoppen S, Sarria B, Carbajal A, Vaquero MP. Iron status biomarkers in iron deficient women consuming oily fish versus red meat diet. J Physiol Biochem. 2009 Jun;65(2):165-74. doi: 10.1007/BF03179067.
- Navas-Carretero S, Perez-Granados AM, Schoppen S, Vaquero MP. An oily fish diet increases insulin sensitivity compared to a red meat diet in young iron-deficient women. Br J Nutr. 2009 Aug;102(4):546-53. doi: 10.1017/S0007114509220794. Epub 2009 Feb 12.
- Navas-Carretero S, Perez-Granados AM, Sarria B, Vaquero MP. Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women. Nutrition. 2009 Jan;25(1):20-4. doi: 10.1016/j.nut.2008.07.002. Epub 2008 Aug 26.
- Navas-Carretero S, Perez-Granados AM, Sarria B, Carbajal A, Pedrosa MM, Roe MA, Fairweather-Tait SJ, Vaquero MP. Oily fish increases iron bioavailability of a phytate rich meal in young iron deficient women. J Am Coll Nutr. 2008 Feb;27(1):96-101. doi: 10.1080/07315724.2008.10719680.
- Navas-Carretero S, Sarria B, Perez-Granados AM, Schoppen S, Izquierdo-Pulido M, Vaquero MP. A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats. Ann Nutr Metab. 2007;51(3):204-7. doi: 10.1159/000104138. Epub 2007 Jun 18.
- Sarria B, Navas-Carretero S, Lopez-Parra AM, Perez-Granados AM, Arroyo-Pardo E, Roe MA, Teucher B, Vaquero MP, Fairweather-Tait SJ. The G277S transferrin mutation does not affect iron absorption in iron deficient women. Eur J Nutr. 2007 Feb;46(1):57-60. doi: 10.1007/s00394-006-0631-x. Epub 2007 Jan 5.
- Toxqui L, De Piero A, Courtois V, Bastida S, Sanchez-Muniz FJ, Vaquero MP. [Iron deficiency and overload. Implications in oxidative stress and cardiovascular health]. Nutr Hosp. 2010 May-Jun;25(3):350-65. Spanish.
- Blanco-Rojo R, Perez-Granados AM, Toxqui L, Zazo P, de la Piedra C, Vaquero MP. Relationship between vitamin D deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food. Eur J Nutr. 2013 Mar;52(2):695-703. doi: 10.1007/s00394-012-0375-8. Epub 2012 May 23.
- Blanco-Rojo R, Perez-Granados AM, Toxqui L, Gonzalez-Vizcayno C, Delgado MA, Vaquero MP. Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: a randomised, double-blind, placebo-controlled study in Spanish iron-deficient women. Br J Nutr. 2011 Jun;105(11):1652-9. doi: 10.1017/S0007114510005490. Epub 2011 Feb 8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2008
Primary Completion (Actual)
January 1, 2009
Study Completion (Actual)
May 1, 2009
Study Registration Dates
First Submitted
May 28, 2010
First Submitted That Met QC Criteria
June 2, 2010
First Posted (Estimate)
June 3, 2010
Study Record Updates
Last Update Posted (Estimate)
December 24, 2012
Last Update Submitted That Met QC Criteria
December 21, 2012
Last Verified
December 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AGL2006/09519/ALI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iron-deficiency Anemia
-
Pennington Biomedical Research CenterCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency Anemia TreatmentUnited States
-
Children's Hospital Los AngelesNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingAnemia | Iron Deficiency Anemia | Anemia, Iron Deficiency | IDA - Iron Deficiency AnemiaUnited States
-
Antalya Training and Research HospitalCompletedIron Deficiency Anemia | Iron Deficiency Anemia TreatmentTurkey
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Tampere University HospitalTampere UniversityRecruitingIron Deficiency | Iron Deficiency Anaemia in Childbirth | Iron Status | Iron Deficiency in Pregnancy | Iron Deficiency Anemia in PregnancyFinland
-
Arrowhead Regional Medical CenterRecruitingIron Deficiency Anemia of PregnancyUnited States
-
CMH Multan Institute of Medical SciencesCompletedPregnancy | Iron Deficiency Anemia (IDA)Pakistan
-
Ain Shams UniversityActive, not recruitingIron Deficiency Anemia TreatmentEgypt
-
Children's Hospital Los AngelesWithdrawnAnemia | Iron-deficiency Anemia | Healthy ControlsUnited States
-
Baylor College of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedIron-deficiency | Iron Deficiency AnemiaUnited States
Clinical Trials on non-fortified fruit juices consumed as part of the usual diet
-
Servicio Canario de SaludCompletedGeneralized Anxiety Disorder | GADSpain
-
Centre Hospitalier Metropole SavoieCompletedDiet Habit | Type I Diabetes | Activity, Motor | ControlFrance